Canlyniadau Chwilio - Gregory M. Springett

  • Dangos 1 - 18 canlyniadau o 18
Mireinio'r Canlyniadau
  1. 1
    Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent

    Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent gan Gregory M. Springett, R C Moen, Stacie M. Anderson, R. Michael Blaese, W. French Anderson

    Cyhoeddwyd 1989
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma

    Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma gan Tomar Ghansah, Nasreen A. Vohra, Kathleen Kinney, Amy Weber, Krithika N. Kodumudi, Gregory M. Springett, Amod A. Sarnaik, Shari Pilon‐Thomas

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Comparative long-term outcomes of upfront resected pancreatic cancer after preoperative biliary drainage

    Comparative long-term outcomes of upfront resected pancreatic cancer after preoperative biliary drainage gan Tobin J. Strom, Jason Klapman, Gregory M. Springett, Kenneth Meredith, Sarah E. Hoffe, Junsung Choi, Pamela J. Hodul, Mokenge P. Malafa, Ravi Shridhar

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E δ-tocotrienol in Patients with Pancreatic Ductal Neoplasia

    A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E δ-tocotrienol in Patients with Pancreatic Ductal Neoplasia gan Gregory M. Springett, Kazim Husain, Anthony Neuger, Barbara A. Centeno, Dung‐Tsa Chen, Tai Hutchinson, Richard M. Lush, Saı̈d M. Sebti, Mokenge P. Malafa

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancer

    Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront p... gan Eric A. Mellon, Tobin J. Strom, Sarah E. Hoffe, Jessica M. Frakes, Gregory M. Springett, Pamela J. Hodul, Mokenge P. Malafa, Michael D. Chuong, Ravi Shridhar

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Neoadjuvant GTX Chemotherapy and IMRT‐based chemoradiation for borderline resectable pancreatic cancer

    Neoadjuvant GTX Chemotherapy and IMRT‐based chemoradiation for borderline resectable pancreatic cancer gan Manish R. Patel, Sarah E. Hoffe, Mokenge P. Malafa, Pamela J. Hodul, Jason Klapman, Barbara A. Centeno, Jongphil Kim, James F. Helm, Tiffany Valone, Gregory M. Springett

    Cyhoeddwyd 2011
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker

    Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker gan Pamela N. Münster, Douglas C. Marchion, Scott Thomas, Merrill J. Egorin, S. Minton, Gregory M. Springett, Ji‐Hyun Lee, George R. Simon, Alberto Chiappori, Dan M. Sullivan, Adil Daud

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy

    Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant ster... gan Eric A. Mellon, William Jin, Jessica M. Frakes, Barbara A. Centeno, Tobin J. Strom, Gregory M. Springett, Mokenge P. Malafa, Ravi Shridhar, Pamela J. Hodul, Sarah E. Hoffe

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer

    Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer gan T. Ström, Sarah E. Hoffe, William J. Fulp, Jessica M. Frakes, Domenico Coppola, Gregory M. Springett, Mokenge P. Malafa, Cynthia L. Harris, Steven A. Eschrich, Javier F. Torres–Roca, Ravi Shridhar

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia

    A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia gan Hiroaki Kawasaki, Gregory M. Springett, Shinichiro Toki, Juan J. Canales, Patricia Harlan, Justin P. Blumenstiel, Emy J. Chen, I. Amy Bany, Naoki Mochizuki, Amy Ashbacher, Michiyuki Matsuda, David E. Housman, Ann M. Graybiel

    Cyhoeddwyd 1998
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Phase I Trial of Poly-<scp>l</scp>-Glutamate Camptothecin (CT-2106) Administered Weekly in Patients with Advanced Solid Malignancies

    Phase I Trial of Poly-<scp>l</scp>-Glutamate Camptothecin (CT-2106) Administered Weekly in Patients with Advanced Solid Malignancies gan Jade Homsi, George R. Simon, Chris R. Garrett, Gregory M. Springett, Ronald De Conti, Alberto Chiappori, Pamela N. Münster, Michelle Burton, Scott Stromatt, Claudia Allievi, Patrizia Angiuli, Amy J. Eisenfeld, Daniel M. Sullivan, Adil Daud

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Phase I Study of Bosutinib, a Src/Abl Tyrosine Kinase Inhibitor, Administered to Patients with Advanced Solid Tumors

    Phase I Study of Bosutinib, a Src/Abl Tyrosine Kinase Inhibitor, Administered to Patients with Advanced Solid Tumors gan Adil Daud, Smitha Krishnamurthi, Mansoor N. Saleh, Barbara J. Gitlitz, Mitesh J. Borad, Philip J. Gold, Elena G. Chiorean, Gregory M. Springett, Richat Abbas, Shefali Agarwal, Nathalie Bardy‐Bouxin, Poe‐Hirr Hsyu, Eric Leip, Kathleen Turnbull, Charles Zacharchuk, Wells A. Messersmith

    Cyhoeddwyd 2011
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors

    Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors gan Adil Daud, Michelle T. Ashworth, Jonathan Strosberg, Jonathan W. Goldman, David S. Mendelson, Gregory M. Springett, Alan P. Venook, Sabine Loechner, Lee S. Rosen, Fergus Shanahan, David Parry, Stuart D. Shumway, Jennifer A. Grabowsky, Tomoko Freshwater, Christopher L. Sorge, Soonmo Peter Kang, Randi Isaacs, Pamela N. Münster

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    A Phase 1 Escalating Single-Dose and Weekly Fixed-Dose Study of Cetuximab: Pharmacokinetic and Pharmacodynamic Rationale for Dosing

    A Phase 1 Escalating Single-Dose and Weekly Fixed-Dose Study of Cetuximab: Pharmacokinetic and Pharmacodynamic Rationale for Dosing gan Paula M. Fracasso, Howard A. Burris, Matthew A. Arquette, Ramaswamy Govindan, Feng Gao, L. Wright, Sherry A. Goodner, F. Anthony Greco, Suzanne F. Jones, Noel T. Willcut, Catherine Chodkiewicz, Amit Pathak, Gregory M. Springett, George R. Simon, Daniel M. Sullivan, Raphaël Marcelpoil, S. Mayfield, David Mauro, Christopher R. Garrett

    Cyhoeddwyd 2007
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Effects of a Brief Multimedia Psychoeducational Intervention on the Attitudes and Interest of Patients With Cancer Regarding Clinical Trial Participation: A Multicenter Randomized Controlled Trial

    Effects of a Brief Multimedia Psychoeducational Intervention on the Attitudes and Interest of Patients With Cancer Regarding Clinical Trial Participation: A Multicenter Randomized... gan Paul B. Jacobsen, Kristen J. Wells, Cathy D. Meade, Gwendolyn P. Quinn, Ji‐Hyun Lee, William J. Fulp, Jhanelle E. Gray, Rachid Baz, Gregory M. Springett, Richard M. Levine, Merry Jennifer Markham, Fred Schreiber, Thomas H. Cartwright, James M. Burke, Robert D. Siegel, Mokenge P. Malafa, Daniel P. Sullivan

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study

    Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study gan Alexandra Gangi, Jehan L. Shah, Nathan Hatfield, J. Joshua Smith, Jennifer Sweeney, Junsung Choi, Ghassan El‐Haddad, B. Biebel, Nainesh Parikh, Bülent Arslan, Sarah E. Hoffe, Jessica M. Frakes, Gregory M. Springett, Daniel A. Anaya, Mokenge P. Malafa, Dung‐Tsa Chen, Yunyun Chen, Richard D. Kim, Ravi Shridhar, Béla Kis

    Cyhoeddwyd 2018
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    A Genome-Wide Investigation of MicroRNA Expression Identifies Biologically-Meaningful MicroRNAs That Distinguish between High-Risk and Low-Risk Intraductal Papillary Mucinous Neoplasms of the Pancreas

    A Genome-Wide Investigation of MicroRNA Expression Identifies Biologically-Meaningful MicroRNAs That Distinguish between High-Risk and Low-Risk Intraductal Papillary Mucinous Neopl... gan Jennifer Permuth‐Wey, Y. Ann Chen, Kate Fisher, Susan McCarthy, Xiaotao Qu, Mark C. Lloyd, Agnieszka Kasprzak, Michelle Fournier, Vonetta L. Williams, Kavita M. Ghia, Sean Yoder, Laura Hall, Christina Georgeades, Funmilayo Olaoye, Kazim Husain, Gregory M. Springett, Dung‐Tsa Chen, Timothy J. Yeatman, Barbara A. Centeno, Jason Klapman, Domenico Coppola, Mokenge P. Malafa

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Safety and Survival With GVAX Pancreas Prime and <i>Listeria Monocytogenes</i>–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer

    Safety and Survival With GVAX Pancreas Prime and <i>Listeria Monocytogenes</i>–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer gan Dung T. Le, Andrea Wang‐Gillam, Vincent J. Picozzi, Tim F. Greten, Todd S. Crocenzi, Gregory M. Springett, Michael A. Morse, Herbert J. Zeh, Deirdre Jill Cohen, Robert L. Fine, Beth Onners, Jennifer N. Uram, Daniel A. Laheru, Eric R. Lutz, Sara Solt, Aimee Murphy, Justin Skoble, Ed Lemmens, John Grous, Thomas W. Dubensky, Dirk G. Brockstedt, Elizabeth M. Jaffee

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: